How Preclinical Testing of Breast Implants Works at INNOPROOF?
Preclinical testing of breast implants is described with international validity in ISO 14607:2024. Fatigue tests (Annexes C.1 and C.3) and impact tests (Annex C.2) are required on the final, sterilized product. With regard to the shell, tensile tests on standardized specimens with measurement of tensile set are required. In addition, the bond between the shell and the seal must be tested in a tensile test (Annex B). For the silicone filling itself, cohesion tests are described in Annex E.
Furthermore, ISO 14607 specifies a measurement of surface topography in Annex H. From this, surface roughness and additional surface parameters are determined, and the classification into smooth, micro-textured, or macro-textured is derived. For inflatable implants, the reliability of the valve or injection site is tested in accordance with Annex D.
For FDA approval, an additional fatigue test must be performed in accordance with FDA Guidance Docket No. 2004D-0124. The aim of this test is the development of a Wöhler (S–N) curve and the determination of the fatigue life of the implant over 6.5 million load cycles. Further tests on breast implants are described in ASTM F703-18. The mechanical testing of the shell corresponds to Annex B of ISO 14607. The testing of inflatable implants corresponds to Annex D. The cohesion test corresponds to Annex E.
A test method described in ASTM F703-18 but not in ISO 14607 is the gel bleeding test. Here, the finished, sterilized product is stored for 8 weeks at elevated temperature, and any silicone leakage through the shell is measured. All of the above-mentioned tests are offered by INNOPROOF GmbH for your products. Further information on the individual tests is provided in the sections below.
Our service portfolio has also been expanded to include tests that are not specified by standards but are described in the literature. This includes, for example, testing the elasticity of the gel filling.
The methods accredited within our scope are marked with * below. Within the framework of the MRA-ILAC agreements, our tests are internationally valid.



As part of our testing services for breast implants, we offer, among other things, tests to assess the integrity of the shell in accordance with ISO 14607:2024, Annex B. These include tests of the shell’s elongation, measurement of tensile set after sustained elongation, and testing of seam strength.
ISO 14607:2024 describes in Annex C.1 the fatigue testing of breast implants under shear stress. The implant is placed between two horizontally arranged plates, and a static load of 50 N per implant is applied. Using an eccentric drive, one of the plates is moved back and forth, applying shear stress to the implant. The test is conducted over 6.5 million cycles at a frequency of 3.33 Hz. Afterwards, an optical rupture inspection is performed.
For the impact test according to ISO 14607:2024 Annex C.2, INNOPROOF has developed and built a custom drop rig that ensures a standard-compliant test. Depending on the mass and projection height of the breast implant, the required drop height is calculated. A weight of 4.4 kg is held by an electromagnet, and the drop height is set using a measuring device. The test specimen is placed centrally on the test table. When the electromagnet is switched off, the weight is released, initiating the impact.
ISO 14607:2024 Annex C.3 and the document Docket No. 2004D-0124 from the U.S. Food and Drug Administration (FDA) describe fatigue tests on breast implants aimed at developing a Wöhler (S–N) curve. Unlike the fatigue tests under shear stress according to ISO 14607, the implants in the FDA guideline Docket No. 2004D-0124 are subjected to cyclic compressive loading. Sinusoidal load cycles with defined upper and lower loads are applied up to a run-out level of 6.5 million cycles. We offer this test together with static rupture tests according to ISO 14607:2007.
Annex D of ISO 14607:2024 describes the testing of the injection site of fillable tissue expanders (breast implants). The injection site is repeatedly pierced at the same spot with a needle while a water column exerts pressure on the passage.
We offer cohesion testing of silicone gel according to ISO 14607:2024 Annex E. In this test, only the filling is examined, not the shell. The silicone filling material is poured into a funnel with standardized dimensions and surface roughness. The gel is allowed to flow freely through the funnel’s lower opening for a duration of (30.0 ± 0.1) minutes.
ASTM F703 describes a test for silicone implants to assess gel bleeding. This test checks the implant for the migration of silicone gel through the elastomer shell. The implants are placed on platinum-cured silicone discs (70 durometer) with a diameter of 50 mm and stored for 8 weeks at 43.3°C. The weight of the silicone discs is measured weekly to determine any change in weight. Control discs, stored under the same conditions without implants, are used to account for variations due to environmental factors. ASTM requires a minimum of three samples of each implant type and three additional control discs.
The testing of gel material properties is conducted using our proprietary BTC-2000 device. The suction unit, which holds the laser unit, is mounted on a microscope stand with a micrometer drive. A scale is positioned on the microscope stand. The basic principle of gel elasticity testing involves applying a vacuum to a portion of the implant gel inside the cylindrical chamber of the suction unit and measuring the gel deformation with a laser. A 1 cm circular area of the implant shell is removed from the apex of the implant, and the gel is dusted with laser toner to enhance laser tracking of the surface.